相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer
N. Kemeny et al.
ANNALS OF ONCOLOGY (2009)
Anatomic variations of the hepatic arteries in 250 patients studied with 64-row CT angiography
Carlo Nicola De Cecco et al.
EUROPEAN RADIOLOGY (2009)
Conversion to Resectability Using Hepatic Artery Infusion Plus Systemic Chemotherapy for the Treatment of Unresectable Liver Metastases From Colorectal Carcinoma
Nancy E. Kemeny et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study
M. L. Rothenberg et al.
ANNALS OF ONCOLOGY (2008)
Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer - A multifactorial model of 929 patients
Myrddin Rees et al.
ANNALS OF SURGERY (2008)
Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer
Hiromichi Ito et al.
ANNALS OF SURGERY (2008)
Robotic-assisted placement of a hepatic artery infusion catheter for regional chemotherapy
Minia Hellan et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2008)
Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure
Valerie Boige et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis
D. J. Gallagher et al.
ANNALS OF ONCOLOGY (2007)
Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer
Josep Tabernero et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases
C. Barone et al.
BRITISH JOURNAL OF CANCER (2007)
Actual 10-year survival after resection of colorectal liver Metastases defines cure
James S. Tomlinson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase I study of AZD0530, an oral potent inhibitor of Src kinase: First demonstration of inhibition of Src activity in human cancers
J. Tabernero et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Improving resectability of hepatic colorectal metastases: Expert consensus statement
Eddie K. Abdalla et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Laparoscopic hepatic artery catheterization for regional chemotherapy - Is this the best current option for liver metastatic disease?
M Franklin et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2006)
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: A randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)
NE Kemeny et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer
N Kemeny et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: A trial of the Gastrointestinal Group of the Federation Nationale des Centres de Lutte Contre le Cancer
M Ducreux et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: An institutional experience of 544 consecutive cases
PJ Allen et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2005)
Hepatic arterial infusion after liver resection
NE Kemeny et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer:: A randomized GERCOR study
C Tournigand et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model
R Dzodic et al.
ANTI-CANCER DRUGS (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver
JMGH van Riel et al.
ANNALS OF ONCOLOGY (2004)
Laparoscopic placement of hepatic artery infusion pumps: Technical considerations and early results
J Cheng et al.
ANNALS OF SURGICAL ONCOLOGY (2004)
Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer
N Kemeny et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Patterns of failure following curative resection of colorectal liver metastases
B Topal et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2003)
Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial
DJ Kerr et al.
LANCET (2003)
Technical complications of continuous intra-arterial chemotherapy with 5-fluorodeoxyuridine and 5-fluorouracil for colorectal liver metastases
S Heinrich et al.
SURGERY (2003)
Hepatic artery chemotherapy for colorectal liver metastases: technical considerations and review of clinical trials
JJ Skitzki et al.
SURGICAL ONCOLOGY-OXFORD (2002)
Trends in long-term survival following liver resection for hepatic colorectal metastases
MA Choti et al.
ANNALS OF SURGERY (2002)
Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - An intergroup study
MM Kemeny et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
分享论文
